MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3.11 Cr | ₹0.50 Cr | ₹0.65 Cr | ₹6.04 Cr | ₹7.84 Cr |
What is the latest Total Non-Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹3.11 Cr |
| Mar2024 | ₹0.50 Cr |
| Mar2023 | ₹0.65 Cr |
| Mar2022 | ₹6.04 Cr |
| Mar2021 | ₹7.84 Cr |
How is Total Non-Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.11 Cr | 524.95 | |
| Mar2024 | ₹0.50 Cr | -23.54 | |
| Mar2023 | ₹0.65 Cr | -89.23 | |
| Mar2022 | ₹6.04 Cr | -23.04 | |
| Mar2021 | ₹7.84 Cr | - | |
Compare Total Non-Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹322.9 Cr | -3.2% | 4.9% | -41.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -3.2% |
4.9% |
-41.4% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses